Photo taken from medicine.yale.edu
Aug 2, 2024, 14:00
Alessandro Santin: This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients
Yale Cancer Center made the following post on X:
“Led by Dr. Alessandro Santin and researchers at Yale Cancer Center, the TROPiCS-03 phase II study for patients with advanced or recurrent endometrial cancer has advanced to a phase III trial. ‘This is a major ‘bench-to-bedside’ accomplishment for uterine cancer patients,’ said Dr. Santin.”
Read further.
Source: Yale Cancer Center/X
advanced endometrial cancer
Alessandro Santin
bench-to-bedside
cancer
cancer treatment advancement
clinical trial progress
Dr. Alessandro Santin
endometrial cancer treatment
OncoDaily
Oncology
oncology research
phase II study
Phase III trial
recurrent endometrial cancer
TROPiCS-03 study
uterine cancer research
Yale Cancer Center
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 14:40
Nov 14, 2024, 14:39
Nov 14, 2024, 14:28
Nov 14, 2024, 14:05
Nov 14, 2024, 13:49